菌体EF-N13作为替代性治疗策略的潜力,用于多药耐药Enterococcus faecalis引起的乳腺炎感染

相关实验视频

Updated: Jul 17, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

Yalu Ji¹, Zhen Zhao¹, Qianming Jiang²

¹State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China.

Journal of dairy science

|August 29, 2023

概括

菌体EF-N13有效地治疗了小鼠多抗药性Enterococcus faecalis乳腺炎. 这种对抗生素有希望的替代品可以减少细菌负载和炎症,显示出牛乳腺炎治疗的潜力.

科学领域:

兽医微生物学兽医微生物学
细菌治疗疗法是一种细菌治疗.
动物传染病动物传染病

背景情况:

牛乳炎是一种昂贵的乳牛疾病,通常是由多药耐药的Enterococcus faecalis引起的.
抗生素耐药性和环境问题促使人们寻找替代治疗方法.
菌体 (菌体) 显示出作为非抗生素治疗剂的潜力.

研究的目的:

在小鼠模型中研究一种新型菌体 (EF-N13) 对多药耐药E. faecalis诱导的乳腺炎的保护效果.
评估隔离的菌体的体外和体内特征,以了解其潜在的治疗应用.

主要方法:

隔离和表征多药耐药的E. faecalis菌株和母乳中的特定菌体 (EF-N13).
在体外评估菌素杀菌活性,生物膜抑制和基因组分析.
菌体EF-N13治疗潜力的体内评估在E. faecalis乳腺炎的小鼠模型中,包括细菌负载,组织病理学和细胞因子分析.

主要成果:

孤立的E. faecalis菌株具有多种耐药性,并且能够形成生物膜.
菌体EF-N13在体外表现出强大的杀菌活性和对E. faecalis.生物膜的预防.
在体内,单次菌体剂量显著降低了乳腺细菌数量,炎症和组织损伤,降低了促炎细胞因子.

结论:

菌体EF-N13对抗多药耐药E. faecalis乳腺炎具有显著的治疗潜力.
EF-N13代表了一种有希望的替代性非抗生素治疗牛乳腺炎的治疗策略.
对牛乳腺炎的菌体治疗进行进一步的研究是有必要的.

关键词:

菌 (Enterococcus faecalis) 是一种菌.生物膜是一种生物膜.乳腺炎是一种乳腺炎.具有多种耐药性的药物.菌体菌体是一种菌体.

更多相关视频

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

相关概念视频

Lytic Cycle of Bacteriophages

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...

Biological Methods for Microbial Control

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...